TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
ESP Life Sciences Consulting AB
Closing information (x1000 NOK)
Closing information | 2024/01 | 2023/01 | 2022/01 |
Turnover |
949
|
741
|
958 |
Financial expenses |
57
|
0
|
5 |
Earnings before taxes |
200
|
283
|
582 |
EBITDA |
258
|
275
|
587 |
Total assets |
1,432
|
1,319
|
1,159 |
Current assets |
1,376
|
1,282
|
1,154 |
Current liabilities |
897
|
468
|
529 |
Equity capital |
521
|
837
|
616 |
- share capital |
50
|
48
![]() |
48 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2024/01 | 2023/01 | 2022/01 |
Solvency |
36.4%
|
63.5%
|
53.1% |
Turnover per employee |
949
|
741
|
958 |
Profit as a percentage of turnover |
21.1%
|
38.2%
|
60.8% |
Return on assets (ROA) |
17.9%
|
21.5%
|
50.6% |
Current ratio |
153.4%
|
273.9%
|
218.1% |
Return on equity (ROE) |
38.4%
|
33.8%
|
94.5% |
Change turnover |
172
|
-223
|
251 |
Change turnover % |
22%
|
-23%
|
36% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/01 | 2023/01 | 2022/01 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.